Neurable Raises $35 Million Series A to Accelerate Consumer Brain-Computer Interface Technology
Neurable, the Boston-area neurotechnology company developing noninvasive brain-computer interface (BCI) technology for everyday consumer applications, has been steadily building its funding base with a series of notable venture investments, positioning itself as one of the emerging leaders in consumer neurotech and cognitive performance tools.
In December 2025, Neurable closed a $35 million Series A funding round aimed at accelerating the commercialization of its compact brain-signal processing platform known as Neurable AI, which integrates BCI capabilities into devices people use daily, such as wearable headsets that provide insights into mental fatigue, focus, and cognitive recovery. The round was led by Spectrum Moonshot Fund, reflecting confidence in Neurable’s potential to bring advanced neurotechnology to mainstream markets through practical products rather than research-only systems. Pace Ventures, an existing investor closely aligned with technology and early-stage startups, also participated in the round, reinforcing support from backers familiar with Neurable’s vision and technical progress.
The Series A financing brought Neurable’s total raised capital to approximately $65 million, counting previous funding rounds and investments to date. This capital injection is intended to help Neurable expand its platform and device ecosystem beyond research settings to broader consumer and enterprise audiences, including cognitive health, human performance, and gaming sectors where brain insights are increasingly valued alongside traditional metrics such as heart rate or sleep patterns.
Before the 2025 Series A round, Neurable had already secured funding in May 2024 through a $13 million financing round that included participation from a group of strategic investors. That round included backing from Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet, providing the company with capital from both venture-focused and growth-oriented investors. The funds were directed toward advancing Neurable’s core platform and expanding licensing opportunities that enable its noninvasive BCI technology to be embedded into consumer products through original equipment manufacturer partnerships.
In addition to private venture funding, Neurable has benefited from development-focused capital through government and research collaborations. The company has worked with the Air Force Research Laboratory’s 711th Human Performance Wing and has secured $5 million in development contracts from the U.S. Department of Defense, further validating the real-world applicability of its technology and supporting continued research and product development.
Founded by CEO and co-founder Dr. Ramses Alcaide, Neurable is focused on unlocking actionable brain data using noninvasive EEG-based systems that can be integrated into everyday head-worn devices. The company’s approach emphasizes practical deployment, enabling users to measure cognitive states such as attention and fatigue in real time. In late 2025, Neurable introduced products such as the MW75 Neuro LT headset, which uses Neurable AI to deliver cognitive insights through companion software applications, marking a significant step toward mainstream commercialization.
Neurable’s investor base reflects a blend of technology-focused funds and strategic partners with experience supporting emerging platforms. Spectrum Moonshot Fund’s leadership in the Series A round signals confidence in the scalability of Neurable’s consumer-focused neurotechnology strategy, while continued participation from Pace Ventures highlights long-term investor alignment. Earlier investors, including Ultratech Capital Partners, TRAC, and Metaplanet, helped establish a diversified funding foundation that supports the company’s long-term vision.
Overall, Neurable’s funding trajectory illustrates growing investor belief that brain-computer interface technology can move beyond laboratories and into everyday products. By combining venture capital, strategic partnerships, and development contracts, Neurable is positioning itself to play a meaningful role in the next generation of human-computer interaction, as interest in cognitive performance and brain health continues to expand across consumer and enterprise markets.
